Watchlist Price Alert

Kairos Pharma Ltd. (KAPA)

AMEX: KAPA · Real-Time Price · USD

0.85

-0.00 (-0.57%)

At close: May 06, 2025, 3:59 PM

Kairos Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-2.6M	-1.81M	-1.05M	-2.15M	-1.05M
Depreciation & Amortization	160K	160K	160K	98K	n/a
Stock-Based Compensation	218K	913K	n/a	300K	800K
Other Working Capital	-1.98M	764K	129K	1.19M	212.82K
Other Non-Cash Items	254K	56K	408K	144K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.98M	764K	129K	1.19M	212.82K
Operating Cash Flow	-3.96M	81K	-353K	-412K	-38.53K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	-109K	n/a
Investing Cash Flow	n/a	n/a	n/a	-109K	n/a
Debt Repayment	n/a	n/a	895K	330K	50K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-390K	-425K	-178K	n/a	-13K
Financial Cash Flow	5.13M	-425K	717K	580K	37K
Net Cash Flow	1.18M	-344K	364K	59K	-1.53K
Free Cash Flow	-3.96M	81K	-353K	-412K	-38.53K